HK1162127A1 - Oil body associated protein compositions and methods as well as use thereof for reducing the risk of cardiovascular disease - Google Patents

Oil body associated protein compositions and methods as well as use thereof for reducing the risk of cardiovascular disease

Info

Publication number
HK1162127A1
HK1162127A1 HK12102742.3A HK12102742A HK1162127A1 HK 1162127 A1 HK1162127 A1 HK 1162127A1 HK 12102742 A HK12102742 A HK 12102742A HK 1162127 A1 HK1162127 A1 HK 1162127A1
Authority
HK
Hong Kong
Prior art keywords
risk
reducing
methods
well
cardiovascular disease
Prior art date
Application number
HK12102742.3A
Other languages
English (en)
Chinese (zh)
Inventor
Neal A Bringe
Kanthasamy Karunanandaa
Original Assignee
Monsanto Technology Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Technology Llc filed Critical Monsanto Technology Llc
Publication of HK1162127A1 publication Critical patent/HK1162127A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/14—Vegetable proteins
    • A23J3/16—Vegetable proteins from soybean
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/347—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of proteins from microorganisms or unicellular algae
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
HK12102742.3A 2002-04-18 2012-03-19 Oil body associated protein compositions and methods as well as use thereof for reducing the risk of cardiovascular disease HK1162127A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37346002P 2002-04-18 2002-04-18

Publications (1)

Publication Number Publication Date
HK1162127A1 true HK1162127A1 (en) 2012-08-24

Family

ID=29251031

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12102742.3A HK1162127A1 (en) 2002-04-18 2012-03-19 Oil body associated protein compositions and methods as well as use thereof for reducing the risk of cardiovascular disease

Country Status (14)

Country Link
US (1) US7541329B2 (no)
EP (1) EP1494536B1 (no)
JP (1) JP5219326B2 (no)
KR (1) KR101238752B1 (no)
CN (2) CN102240040B (no)
AU (1) AU2003221982B2 (no)
BR (1) BRPI0309421B8 (no)
CA (1) CA2482464C (no)
HK (1) HK1162127A1 (no)
IL (1) IL164647A (no)
MX (1) MXPA04010310A (no)
NO (1) NO333937B1 (no)
NZ (1) NZ536466A (no)
WO (1) WO2003088749A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20020147A1 (it) * 2002-01-29 2003-07-29 Indena Spa Estrazione purificazione e modificazione di polipeptidi da seme di soia
EP1799831A4 (en) * 2004-10-06 2007-11-21 Sembiosys Genetics Inc PROCESS FOR MODULATING OLEOSINE EXPRESSION IN PLANTS
JPWO2006101181A1 (ja) * 2005-03-23 2008-09-04 不二製油株式会社 肝機能障害予防もしくは改善組成物、及び肝機能障害予防もしくは改善法
WO2007026674A1 (ja) * 2005-08-29 2007-03-08 Fuji Oil Company, Limited 大豆蛋白質組成物を配合する麺類および麺皮類
US7695744B1 (en) 2005-11-16 2010-04-13 Kareem M Zubair Natural supplement of cholesterol lowering oil seeds and nuts and method of manufacture
JP4963044B2 (ja) * 2006-07-05 2012-06-27 不二製油株式会社 ユビキチンリガーゼ阻害剤
JP3944864B1 (ja) * 2006-07-31 2007-07-18 株式会社Ｊ−オイルミルズ メタボリックシンドロームの予防および改善用組成物
US9101161B2 (en) * 2006-11-02 2015-08-11 The Coca-Cola Company High-potency sweetener composition with phytoestrogen and compositions sweetened therewith
JP5257074B2 (ja) 2006-12-14 2013-08-07 不二製油株式会社 大豆蛋白質組成物を配合する麺類および麺皮類
WO2009089115A1 (en) * 2008-01-04 2009-07-16 Hormel Foods Corporation Encapsulation of oxidatively unstable compounds
US20110020519A1 (en) * 2008-01-04 2011-01-27 Aveka, Inc. Encapsulation of oxidatively unstable compounds
JP5752874B2 (ja) * 2008-08-08 2015-07-22 株式会社ファンケル 血流改善組成物
WO2010137875A2 (ko) 2009-05-26 2010-12-02 (주)아모레퍼시픽 콩 추출물을 함유하는 혈액 순환 개선 및 혈관 건강 증진용 조성물
WO2012029060A2 (en) * 2010-08-30 2012-03-08 Ben-Gurion University Of The Negev Research And Development Authority Oil globule protein and uses thereof
WO2012097220A2 (en) * 2011-01-13 2012-07-19 The Trustees Of The University Of Pennsylvania Novel vesicles and nanostructures from recombinant proteins
US20140024714A1 (en) * 2011-02-07 2014-01-23 Commonwealth Scientific And Industrial Research Organisation Artificial oil bodies
WO2013052853A2 (en) * 2011-10-07 2013-04-11 Purdue Research Foundation Products containing partially hydrolyzed soy beta-conglycinin, and related methods

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3642490A (en) 1967-03-27 1972-02-15 Ralston Purina Co Method of treating vegetable protein
US3694221A (en) 1970-01-30 1972-09-26 Ralston Purina Co Enzyme modified protein process
US4360537A (en) 1976-05-03 1982-11-23 International Telephone And Telegraph Corporation Lipoprotein emulsions for food use and methods for preparing the same
NZ183822A (en) * 1976-05-03 1980-05-08 Itt Method for preparing a lipoprotein emulsion :an egg yolk replacer
US5725899A (en) * 1978-03-16 1998-03-10 Cole; Morton S. Protein-lipid emulsifying and gelling composition and method of preparing same
CN86105538A (zh) 1986-07-25 1988-02-24 平乡县粮食局油脂加工厂 一种食用油精炼方法
JPH0725796B1 (no) * 1987-08-07 1995-03-22 Fuji Oil Co Ltd
WO1989001495A1 (en) 1987-08-07 1989-02-23 Fuji Oil Company, Limited Cholesterol-level depressant
CA2077020A1 (en) 1991-09-03 1993-03-04 Yoshikazu Isono Process for producing lipoprotein-containing substance having reduced lipid content and food containing substance thus produced
FR2681219B1 (fr) 1991-09-16 1993-11-26 Ard Sa Produit lipidoproteique derive de la farine de ble, son procede de preparation et ses applications.
JPH05168428A (ja) * 1991-12-21 1993-07-02 Yuichiro Onozuka 大豆からの麺状食品製造法
USRE40792E1 (en) * 1992-05-19 2009-06-23 Novogen Research Pty Ltd Health supplements containing phyto-oestrogens, analogues or metabolites thereof
US5559220A (en) * 1993-09-14 1996-09-24 Midwest Research Institute Gene encoding acetyl-coenzyme A carboxylase
KR100458809B1 (ko) * 1995-09-06 2005-09-08 교와 핫꼬 고교 가부시끼가이샤 지질대사개선제
US5968516A (en) * 1995-10-03 1999-10-19 Liu; Yaguang Soybean drug and new method of extracting soybean saponins
PT902624E (pt) * 1996-02-29 2001-04-30 Nutri Pharma As Composicao e sua utilizacao como suplemento alimentar ou para diminuir os lipidos no soro
US6171640B1 (en) 1997-04-04 2001-01-09 Monsanto Company High beta-conglycinin products and their use
US5855892A (en) * 1997-09-19 1999-01-05 Potter; Susan M. Method for decreasing LDL-cholesterol concentration and increasing HDL-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease
DE69936837T2 (de) * 1998-01-07 2008-05-08 Diamond, George B. Knusprige frittierprodukte in traubenkeimoel
WO1999045961A1 (en) * 1998-03-12 1999-09-16 Board Of Trustees Of The University Of Arkansas Tertiary structure of peanut allergen ara h 1
JP3030339B2 (ja) * 1998-08-07 2000-04-10 農林水産省農業生物資源研究所長 ダイズグリシニンを発現するトランスジェニック植物
WO2000030663A1 (en) * 1998-11-25 2000-06-02 Nutri Pharma Asa Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of type 2 diabetes, the metabolic syndrome and associated cardiovascular diseases
MXPA01005276A (es) 1998-11-25 2002-04-24 Sembiosys Genetics Inc Cuerpos grasos como vehiculos de suministro topico para agentes activos.
US6544566B1 (en) * 1999-04-23 2003-04-08 Protein Technologies International, Inc. Composition containing plant sterol, soy protein and isoflavone for reducing LDL cholesterol
US6413569B1 (en) * 1999-09-29 2002-07-02 Archer-Daniels-Midland Company Use of isolated soy protein for making fresh, unripened cheese analogs
JP3441411B2 (ja) 1999-10-12 2003-09-02 明治乳業株式会社 コレステロール低減化ペプチド
WO2001036648A1 (en) 1999-11-18 2001-05-25 Societe Des Produits Nestle S.A. Recombinant oleosins from cacao and their use as flavoring or emulsifying agents
US6864362B2 (en) * 2000-03-16 2005-03-08 E. I. Du Pont De Nemours And Company Hypoallergenic transgenic soybeans
JP3619137B2 (ja) 2000-09-28 2005-02-09 日本水産株式会社 オイルボディ様またはシェル状ナノカプセルおよびその製造方法
WO2002026788A1 (fr) * 2000-09-28 2002-04-04 Ajinomoto Co., Inc. Complexe oleosine/phospholipide et procede de production associe
AU2001290324A1 (en) * 2000-09-29 2002-04-08 Fuji Oil Company Limited Composition for diminishing neutral fat in blood
AU9229101A (en) * 2000-10-02 2002-04-15 Fuji Oil Co Ltd Fractionated soybean protein and process for producing the same

Also Published As

Publication number Publication date
JP5219326B2 (ja) 2013-06-26
BR0309421A (pt) 2005-02-01
BRPI0309421B8 (pt) 2021-05-25
CN102240040A (zh) 2011-11-16
AU2003221982B2 (en) 2009-04-23
IL164647A (en) 2009-07-20
CN102240040B (zh) 2014-12-24
NO20044575L (no) 2005-01-17
US7541329B2 (en) 2009-06-02
AU2003221982A1 (en) 2003-11-03
BRPI0309421B1 (pt) 2018-06-26
US20050214346A1 (en) 2005-09-29
CA2482464C (en) 2013-06-25
NZ536466A (en) 2008-04-30
EP1494536A4 (en) 2009-10-28
EP1494536B1 (en) 2013-06-19
KR101238752B1 (ko) 2013-03-06
CN1662142A (zh) 2005-08-31
MXPA04010310A (es) 2005-02-17
CA2482464A1 (en) 2003-10-30
WO2003088749A1 (en) 2003-10-30
EP1494536A1 (en) 2005-01-12
NO333937B1 (no) 2013-10-28
IL164647A0 (en) 2005-12-18
JP2005523007A (ja) 2005-08-04
BRPI0309421A8 (pt) 2017-12-05
KR20050060031A (ko) 2005-06-21

Similar Documents

Publication Publication Date Title
HK1162127A1 (en) Oil body associated protein compositions and methods as well as use thereof for reducing the risk of cardiovascular disease
EP1575480A4 (en) COMPOSITIONS AND METHODS FOR TREATING DISEASES RELATED TO THE IMMUNE SYSTEM
EP1578367A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE DISEASES
EP1572116A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE DISEASES
EP1576137A4 (en) COMPOSITIONS AND METHODS FOR TREATING DISEASES RELATED TO THE IMMUNE SYSTEM
IL218357A0 (en) Compositions and methods of using angiopoietin-like 4 protein
AU2003259735A8 (en) Small-mer compositions and methods of use
EP1571968A4 (en) COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TUMORS
EP1589933A4 (en) COMPOSITIONS AND METHODS FOR DIETUMOR DIAGNOSIS AND TREATMENT
EP1416961A4 (en) COMPOSITION AND METHOD FOR THE TREATMENT OF A DISEASE
IL172689A0 (en) Pro104 ANTIBODY COMPOSITIONS AND METHODS OF USE
WO2004024097A9 (en) Compositions and methods for the treatment of immune related diseases
EP1572091A4 (en) COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING TUMORS
AU2003223579A8 (en) Combinations of cox-2 inhibitors and other agents for the treatment of parkinson's disease
EP1578996A4 (en) COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING TUMORS
EP1553912A4 (en) COMPOSITIONS AND METHODS FOR TUMOR DIAGNOSIS AND TREATMENT
EP1560593A4 (en) NEW COMPOSITION AND METHOD FOR THE TREATMENT OF IMMUNE DISEASES
ZA200605555B (en) Compositions and methods of administering tubulin binding agents for the treatment of ocular disease
EP1575571A4 (en) COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING A TUMOR
AU2003286741A8 (en) Methods and compositions for diagnosis and therapy of parkin-associated disorders
EP1680145A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROLOGICAL DISEASES
EP1594510A4 (en) METHOD AND KIT FOR REDUCING SYMPTOMS OF DISORDERS OF THE PERIPHERAL VASCULAR SYSTEM
AU2003299441A8 (en) Nf-hev compositions and methods of use
EP1663255A4 (en) WITHANAMID AND WITHANOLID COMPOSITIONS AND APPLICATION METHOD THEREFOR
EP1765331A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF PULMONARY DISEASES

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20230416